Background Few studies present prospective data on the incidence of asthma.
The epidemiology of asthma would be better understood if there were more information about factors affecting incidence-that is, the rate at which new cases of asthma appear in the population. Direct measurement of incidence is difficult because it requires regular follow up of large cohorts of non-asthmatic individuals over long periods. Most of our present knowledge is based on period prevalence-that is, the proportion of the population with a history of asthma over a prior period, but this is influenced not only by incidence but also by prognosis. Prevalence studies, being cross sectional, are subject to recall bias and give rise to difficulties in separating cause and effect.
The National Child Development Study has followed a British national cohort of over 17 414 children born during one week in March 1958. Data are available for the perinatal period and at ages 7, 11, 16, and 23 years. It provides a rare opportunity to describe the incidence of asthma in the early years of life in a large and representative sample.
We have reported previously some of the findings relating to asthma up to the age of 16 years.' The present paper extends this analysis to the age of 23 years and for the first time incorporates a multiple regression analysis to examine the independent effects of three important predictors of incidence: sex, hay fever, and eczema.
Methods
Data for the appropriate variables were obtained from the Economic and Social Research Council Data Archive at Essex University and additional variables were extracted from the microfilm records by the authors. At each sweep, data about asthma or wheezing illness were available as follows: Sweep 1. At 7 years of age the parents of the subjects were asked whether their child had ever had "attacks of asthma," and the same question was repeated for "bronchitis with wheezing." For each question, the number of attacks in the past 12 months was recorded. Sweep 2. At 11 years of age the parents were asked whether their child had ever had attacks of "asthma," "wheezing bronchitis" or "neither of these," and if so respectively, df = 1). We therefore explored the relationship between the incidence of asthma or wheezing and the number of atopic diseases at the end of each study period in a similar series of models to those described for prior atopy.
As with prior atopy, both eczema and hay fever were associated independently with Table 6 shows the incidence of asthma or wheezy bronchitis for each study period by the number of atopic diseases reported before the study period and the number reported in the past year at the end of the study period. The results for each study period were similar, with atopy at the end ofthe study period exerting the stronger influence. After adjustment for the number ofatopic conditions reported at the end of the study period, the effect of the number of prior atopic conditions did not approach conventional levels of significance in any of these models (X2 = 2 57, 2-89, and 1-93 at ages 8 to 11
years, 12 to 16 years and 17 to 23 years respectively, df = 1) (table 5) .
Discussion
In this paper we have concentrated on the incidence of asthma or wheezy bronchitis because it is a fundamental indicator of disease occurrence about which we have little direct evidence. To obtain incidence data directly requires the follow up of a large cohort of healthy individuals over a long time, but the very nature of such a study leads to various problems that may affect the validity ofthe data. Firstly, such a study is unlikely to be mounted to investigate asthma alone and in the case of the National Child Development Study the health aspects were in fact a minor part of an essentially social and educational study. Thus the measurements of asthma were minimal and were not designed or timed with the needs of epidemiologists in mind. In particular, the wording of the questions varied from sweep to sweep and could have led to underascertainment of asthma by excluding wheezy subjects without "asthma" and whose wheezing was not associated with "bronchitis." It is reassuring that the prevalence estimates obtained were similar to those obtained in other studies at corresponding points of time. 4 Despite these possible deficiencies, we believe that there are sufficient data from which to construct a valuable picture of the incidence of asthma and wheezing illness from birth to 23 years of age. The second problem, and one that is inherent in any multiple follow up study, is that the incomplete response rates at each sweep, though individually acceptable, tend to accumulate when the data are linked to reduce the overall response even further. Comparison of 12 month period prevalence estimates in those with linked data with those for all subjects seen at any one sweep showed only small differences (up to 5 % in relative terms). Factors associated with non-response at each sweep up to 16 years of age have been exhaustively analysed by Fogelman.5 Not surprisingly, the strongest influence was social class. We have previously shown, however, that social class is not a predictor of asthma incidence up to 16 years of age and it is therefore unlikely that response bias will have affected measures of incidence. More importantly, it is difficult to see how factors associated with non-response could have biased our analyses of the effects of atopy and sex on asthma. The strengths of the National Child Development Study should also be emphasised. These include its large sample size and national coverage.
The observation that incidence is highest in early childhood is consistent with studies reporting the age at onset among prevalent cases.6 However, such estimates could be biased towards those continuing to have wheeze. At the age of 16 years parents of the cohort were asked about the age at onset of their child's asthma; the pattern of age at onset reported retrospectively in this way corresponded closely to the pattern derived from the linked data. Nevertheless, comparison of the reported lifetime prevalence at each sweep (table 1) with the cumulative estimates (table 2) clearly demonstrates the unreliability of prevalence surveys for ascertaining the proportion of subjects with a past history of wheeze.
For example, at 16 years the estimate of lifetime prevalence based on parental recall was 11 5%, whereas that obtained by using cumulative data was 24-5%.
The incidence of asthma or wheezy bronchitis during the 11 to 16 and 17 to 23 year study periods (07-0-8% per year) compares with the figure of 0-6% per year between 7 and 20 years observed by Giles et al among a smaller cohort in Tasmania.7 It is also remarkably similar to a figure of 0-6% per year reported for physician diagnosed asthma in a cohort of 770 children aged between 7 and 23 years in the USA.8 The cumulative incidence of about 30% is similar to that obtained by studies of general practice records."' The only incidence study of comparable size to the National Child Development Study is a ten year follow up of the US National Health and Nutrition Examination Survey cohort of 14 404 subjects, but this involved only adults and used physician diagnosed asthma as the defining criterion.'2 One observation from this US study was that although the prevalence was similar in males and females incidence was higher in females. This pattern is seen at the end of the observation period in the National Child Development Study and emphasises the added contribution of incidence data to understanding the epidemiology of asthma.
A male excess is usually found in the prevalence of childhood asthma, but surprisingly this increased rather than decreased up to 16 years of age; between 16 and 23 years there was a marked sex reversal. This crossover is also seen in hospital admission and mortality data for England and Wales. The net effect of these patterns was that by the age of 23 years the two sexes had experienced almost the same cumulative incidence. The reasons for these sex effects are unknown. We have previously shown that incidence of childhood asthma to 16 years is not affected by the age at onset of menarche or puberty,' which suggests that the explanation is not related to hormonal changes occurring at that time. Perhaps, as with some other developmental phenomena, the development of atopy varies between the sexes in early childhood but females eventually catch up. Another possibility is that from the age ofabout 16 years girls begin to experience a different exposure to certain allergens and irritants.
The cohort approach has major advantages in examining the influence of prior risk factors such as atopy because it avoids the recall bias inherent in any cross sectional approach. It does not, however, avoid the possibility that prior atopy might have biased the way in which subsequent respiratory symptoms were interpreted, labelled and reported. In our study, the inclusion of children with episodes labelled as wheezy bronchitis, as well as those diagnosed as asthma, reduced the opportunity for such bias.
The effect of other atopic disease on the incidence ofasthma was independent of sex and a good fit to the data was obtained by modelling in terms of the number of atopic conditions. However, with relatively small numbers of incident events, we lack the power to discriminate risks in some subgroups (especially in those with both eczema and hay fever).
The effect of prior atopy on the incidence of asthma or wheezy bronchitis is useful for clinical prediction but seems to be almost entirely "explained" by its ability also to predict atopic disease present at the end of follow up. It may be that the truly influential variable is the degree of atopy active at the time of asthma incidence; this could explain the weak and statistically insignificant independent effect of prior atopy in the multivariate models in table 5, since atopic activity in the earlier part of each study period may be more closely related to prior atopy than to atopy at the end of the period.
Eczema was as strongly related to the incidence of asthma as was hay fever. This suggests that the association between atopic activity and the incidence of asthma is not due to inhaled precipitants such as aeroallergens, but that it is the degree of endogenous susceptibility to all forms of atopic disease that is of biological importance in the development of asthma during childhood and adolescence. We are currently examining the association be-tween the incidence of asthma and social and environmental variables in the National Child Developent Study dataset. This analysis will take into account atopic disease as a possible intermediate factor or effect modifier.
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